irblog.prnewswire.com

New clinical study demonstrates TRUCLEAR 5.0 System as a favorable treatment for a common gynecological condition, right in the doctor's office

LONDON, April 24, 2014 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of a new multicenter clinical study which compares the ...
irblog.prnewswire.com

Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids

ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division today announced that its TRUCLEAR™ System, an operative hysteroscopy device for the removal of ...
Medindia

TRUCLEAR™ 5.0 System offers US surgeons a patient-friendly option for removing intrauterine polyps in office or clinical setting

June 6, 2012 Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, announces its TRUCLEAR 5.0 System, the smallest hysteroscopic morcellator system(1) to receive 510(k) ...
Medindia

Smith & Nephew Endoscopy Announces Availability of TRUCLEAR(TM) Hysteroscopic Morcellator at the AAGL Annual Meeting

ANDOVER, Mass., Nov. 17 Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the ...
ETHealthworld

India Medtronic launches TruClear system for treatment of intra uterine abnormalities

Unlike other intra uterine abnormality treatment options that use a high-frequency electric current, the TruClear system uses a simple mechanical approach to remove intrauterine tissue. Therefore, ...